A new experimental and clinical approach of combining usage of highly active tumor-infiltrating lymphocytes and highly sensitive antitumor drugs for the advanced malignant tumor.

Li, B R; Tong, S Q; Zhang, X H; Lu, J; Gu, Q L; Lu, D Y

Li, B R; Tong, S Q; Zhang, X H; Lu, J; Gu, Q L; Lu, D Y.

Affiliation

Li BR; Department of Microbiology, Shanghai Second Medical University.

Chin Med J (Engl) ; 107(11): 803-7, 1994 Nov.

Article in En | MEDLINE | ID: mdl-7867384

Subject(s)

Antineoplastic Agents/therapeutic use; Immunotherapy, Adoptive; Liver Neoplasms/therapy; Lung Neoplasms/therapy; Lymphocytes, Tumor-Infiltrating/immunology; Colonic Neoplasms/pathology; Colonic Neoplasms/therapy; Cytotoxicity, Immunologic; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms/pathology; Lung Neoplasms/pathology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Immunotherapy, Adoptive / Lymphocytes, Tumor-Infiltrating / Liver Neoplasms / Lung Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Chin Med J (Engl) Year: 1994 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links